drugset / Trial / NCT01479556
Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain
RandomizedCrossoverTriple-blindTreatment
Summary
This study is a phase IV clinical trial with the objective of evaluating whether pain relief associated with pregabalin for at-level non-evoked and evoked neuropathic pain is more efficient during the early rather than late subacute phase of spinal cord injury.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-05
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 150 mg | Oral |